Note: EPS may not be comparable

DURECT Corp (NASDAQ: DRRX) reported Q4 EPS of $0.05, $0.11 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $19.54 million versus the consensus estimate of $3.31 million.

• Total revenues were $19.5 million and net profit was $8.2 million for the three months ended December 31, 2017 as compared to total revenues of $3.5 million and net loss of $8.8 million for the three months ended December 31, 2016. The revenues for the three months ended December 31, 2017 included the recognition of the remaining $15.4 million in deferred revenue from the $20 million upfront fee associated with our agreement with Sandoz; this revenue during the fourth quarter period was a non-cash item as the $20 million fee was received in the second quarter of 2017.
• Total revenues were $49.2 million and net loss was $3.7 million for the year ended December 31, 2017, compared to total revenues of $14.0 million and net loss of $34.5 million for the year ended December 31, 2016.
• At December 31, 2017, cash and investments were $36.9 million, compared to cash and investments of $25.2 million at December 31, 2016. Debt at December 31, 2017 was $19.9 million.

For earnings history and earnings-related data on DURECT Corp (DRRX) click here.